A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation

NCT05652205 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Functional Constipation (FC)
Chronic Idiopathic Constipation (CIC)

Interventions

DRUG: Placebo for Linaclotide
DRUG: Linaclotide

Sponsor

AbbVie

Collaborators

[object Object]